Hereditary Breast and Ovarian Cancer Syndrome Associated with a Pathogenic BRCA۱ Variant: A Familial Case Series of Six Sisters

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 48

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JAMPBR-2-3_007

تاریخ نمایه سازی: 20 آبان 1405

چکیده مقاله:

Background: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is most commonly associated with pathogenic variants in the BRCA۱ gene and characterized by an increased lifetime risk of breast and ovarian cancers with variable penetrance. Familial case series provide valuable insights into genotype–phenotype correlations and the impact of preventive strategies.Case Presentation: We report a family consisting of six sisters, four of whom were confirmed carriers of a pathogenic BRCA۱ frameshift mutation (c.۶۸_۶۹del; p.Glu۲۳ValfsTer۱۷). Among the mutation carriers, two developed breast cancer, one developed ovarian cancer, and one developed both breast and ovarian cancer. The proband, a ۴۴-year-old woman, was initially diagnosed with ductal carcinoma in situ of the breast, followed by high-grade serous ovarian carcinoma two years later. She underwent partial mastectomy, total abdominal hysterectomy with bilateral salpingo-oophorectomy, platinum-based chemotherapy, and is currently receiving maintenance therapy with olaparib. One BRCA۱-positive sister underwent prophylactic gynecologic surgery and remains disease-free, while two sisters tested negative for the mutation and have no evidence of malignancy. A significant family history noted in a paternal aunt with early-onset breast cancer followed by ovarian cancer.Discussion: This case series demonstrates the heterogeneous clinical expression of a single pathogenic BRCA۱ mutation within one family, ranging from prophylactic surgery without malignancy to metachronous breast and ovarian cancers. The findings highlight the importance of cascade genetic testing, adherence to guideline-recommended surveillance, and timely risk-reducing interventions. Socioeconomic factors may influence access to preventive surgeries and considered in clinical decision-making. Conclusion: This familial case series highlights the marked clinical heterogeneity of BRCA۱-associated malignancies, even among individuals carrying the same pathogenic variant. The findings underscore the critical role of early genetic testing, cascade screening, and adherence to guideline-recommended surveillance and risk-reducing strategies.

کلیدواژه ها:

نویسندگان

Fatemah Zahra Sadat Allameh

Gynecologist, University of Isfahan, Isfahan, Iran

Nasim Alinezhad

Gynecologist, University of Isfahan, Isfahan, Iran

Amir Bahreini

Medical Genetic, karyoGen, Isfahan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • References[۱] Kerr, S. M., Cowan, E., Klaric, L., Bell, C., ...
  • Agaoglu, N. B., & the writing group. (۲۰۲۲). Concurrent pathogenic ...
  • Villy, M. C., & collaborators. (۲۰۲۱). Co-occurrence of germline BRCA۱ ...
  • Frontiers in Oncology. (۲۰۲۵). Case report: Functional validation of a ...
  • Gracia-Aznarez, F. J., & the research group. (۲۰۲۰). Founder BRCA۱/BRCA۲/PALB۲ ...
  • Manchanda, R., & colleagues. (۲۰۲۰). Economic evaluation of population-based BRCA۱/BRCA۲ ...
  • Hu, C., & the CARRIERS Consortium. (۲۰۲۱). Breast cancer risk ...
  • Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, ...
  • Breast Cancer Association Consortium. (۲۰۲۱). Polygenic risk scores for breast ...
  • Tischkowitz, M., & the screening working group. (۲۰۲۰). Population screening ...
  • Grzymski, J. J., & the Healthy Nevada Project® team. (۲۰۲۲). ...
  • Manickam, K., & colleagues. (۲۰۱۸). Exome sequencing–based screening for BRCA۱/۲ ...
  • Domchek, S. M., & Robson, M. E. (۲۰۲۱). Update on ...
  • Tung, N., & Garber, J. E. (۲۰۲۲). BRCA۱/۲ testing: Therapeutic ...
  • Maxwell, K. N., & the collaborating investigators. (۲۰۲۱). The clinical ...
  • Rebbeck, T. R., & the consortium of investigators. (۲۰۲۰). Mutational ...
  • Parsons, M. T., & the ENIGMA consortium. (۲۰۲۰). Large-scale multifactorial ...
  • Cline, M. S., & the BRCA Challenge contributors. (۲۰۲۰). BRCA ...
  • Li, H., & the UK Biobank cardiometabolic working group. (۲۰۲۲). ...
  • Shirts, B. H., & the clinical validation team. (۲۰۲۲). Clinical ...
  • نمایش کامل مراجع